Meta Healthcare
Pipeline
Medical nutritionMH-315Co-development

MetaCore MSUD

Maple syrup urine disease (MSUD)

RegulatoryStage 5 of 6

A medical nutrition product being advanced through regulatory notification routes for the dietary management of MSUD, with a regional partner supporting EU readiness.

Indication
Dietary management of MSUD
Patient population
Paediatric and adult patients
Regulatory status
UK notification in progress; EU dossier in preparation
Geography
United Kingdom · European Union
Partner status
Co-development

Subject to regulatory notification. Not yet available in all listed territories.

Information on this page describes products and programmes under development or commercialised by Meta Healthcare. Statements about development status and regulatory progress are factual and do not constitute claims of efficacy, superiority or regulatory certainty. Programmes under evaluation are not approved for marketing in all listed territories. Medical nutrition and medical food products should be used under the supervision of a healthcare professional.